Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Plos Genetics|December 25, 2013
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemiaZeynep Kalender Atak, Valentina Gianfelici, Gert Hulselmans, et al.
Frontiers in Oncology|February 3, 2023
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemiaFabio Giglio, Edoardo Campodonico, Francesca Lorentino, et al.
Blood|August 31, 2012
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cellsMarta Coscia, Candida Vitale, Silvia Peola, et al.
Haematologica|September 8, 2018
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaAnna Lucia Fedullo, Monica Messina, Loredana Elia, et al.
Haematologica|January 13, 2010
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adultsPaolo Gorello, Roberta La Starza, Emanuela Varasano, et al.
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Annals of Hematology|July 24, 2025
Semen quality in acute leukemia patients: a retrospective studyAlessandra Buonacquisto, Maria Ilaria Del Principe, Francesco Pallotti, et al.
Blood Cancer Journal|May 2, 2026
Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countriesSabina Chiaretti, Sabine Blum, Thibaut Leguay, et al.
Genes, Chromosomes & Cancer|February 15, 2011
Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profilingSabina Chiaretti, Simona Tavolaro, Marilisa Marinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP reportGiovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Plos Genetics|December 25, 2013
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemiaZeynep Kalender Atak, Valentina Gianfelici, Gert Hulselmans, et al.
Frontiers in Oncology|February 3, 2023
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemiaFabio Giglio, Edoardo Campodonico, Francesca Lorentino, et al.
Blood|August 31, 2012
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cellsMarta Coscia, Candida Vitale, Silvia Peola, et al.
Haematologica|September 8, 2018
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaAnna Lucia Fedullo, Monica Messina, Loredana Elia, et al.
Haematologica|January 13, 2010
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adultsPaolo Gorello, Roberta La Starza, Emanuela Varasano, et al.
Blood Cancer Journal|November 20, 2024
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomabElias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, et al.
Annals of Hematology|July 24, 2025
Semen quality in acute leukemia patients: a retrospective studyAlessandra Buonacquisto, Maria Ilaria Del Principe, Francesco Pallotti, et al.
Blood Cancer Journal|May 2, 2026
Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countriesSabina Chiaretti, Sabine Blum, Thibaut Leguay, et al.
Genes, Chromosomes & Cancer|February 15, 2011
Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profilingSabina Chiaretti, Simona Tavolaro, Marilisa Marinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP reportGiovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.
Pageof 18